www.reuters.com Open in urlscan Pro
2600:9000:235a:2a00:15:5a3e:9d40:93a1  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main content

Exclusive news, data and analytics for financial market professionalsLearn more
aboutRefinitiv

 * World
   Browse World
    * Africa
    * Americas
    * Asia Pacific
    * China
    * Europe
    * India
    * Israel and Hamas at War
   
    * Japan
    * Middle East
    * Ukraine and Russia at War
    * United Kingdom
    * United States
    * Reuters NEXT

 * US Election
 * Business
   Browse Business
    * Aerospace & Defense
    * Autos & Transportation
    * Davos
    * Energy
    * Environment
    * Finance
    * Healthcare & Pharmaceuticals
   
    * Media & Telecom
    * Retail & Consumer
    * Future of Health
    * Future of Money
    * Take Five
    * World at Work

 * Markets
   Browse Markets
    * Asian Markets
    * Carbon Markets
    * Commodities
    * Currencies
    * Deals
    * Emerging Markets
    * ETFs
    * European Markets
   
    * Funds
    * Global Market Data
    * Rates & Bonds
    * Stocks
    * U.S. Markets
    * Wealth
    * Macro Matters

 * Sustainability
   Browse Sustainability
    * Boards, Policy & Regulation
    * Climate & Energy
    * Land Use & Biodiversity
    * Society & Equity
   
    * Sustainable Finance & Reporting
    * The Switch
    * Reuters Impact
    * COP29

 * Legal
   Browse Legal
    * Government
    * Legal Industry
    * Litigation
    * Transactional
    * US Supreme Court

 * Breakingviews
   Browse Breakingviews
    * Breakingviews Predictions

 * Technology
   Browse Technology
    * Artificial Intelligence
    * Cybersecurity
    * Space
    * Disrupted

 * More
   Investigations
   Sports
    * Athletics
    * Baseball
    * Basketball
    * Cricket
    * Cycling
    * Formula 1
    * Golf
    * NFL
    * NHL
    * Soccer
    * Tennis
   
   Science
   Lifestyle
   Graphics
   Pictures
   Wider Image
   Podcasts
   Fact Check
   Video
   Sponsored Content
    * Reuters Plus
    * Press Releases
   
   Live

My News

Sign InSubscribe



CANADA APPROVES NOVO NORDISK'S OBESITY DRUG TO REDUCE RISK OF NON-FATAL HEART
ATTACK

By Reuters
November 27, 20247:24 PM GMT+1Updated 7 hours ago
Text
 * Small Text
 * Medium Text
 * Large Text

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Boxes of Wegovy move along a packaging line at Novo Nordisk's facility in
Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little/File Photo Purchase
Licensing Rights, opens new tab
Nov 27 (Reuters) - Canada's health regulator has approved Novo Nordisk's
(NOVOb.CO), opens new tab weight loss drug Wegovy to reduce the risk of nonfatal
heart attack or myocardial infarction in some adults, the Danish drugmaker said
on Wednesday.
Wegovy has become the first approved treatment in Canada to address both obesity
and the risk of heart-related conditions in adults with established
cardiovascular disease, according to Novo.
Advertisement · Scroll to continue

The European Union health regulator recently backed the drug for reducing the
risk of major cardiovascular events and strokes in overweight or obese adults
without diabetes.
Wegovy is also approved in the UK and the U.S. to lower the risk of serious
heart problems or strokes in overweight and obese adults.
The drug, chemically known as semaglutide, has been authorized in Canada to
treat obesity since 2021.

Keep up with the latest medical breakthroughs and healthcare trends with the
Reuters Health Rounds newsletter. Sign up here.

Reporting by Mariam Sunny in Bengaluru; Editing by Tasim Zahid

Our Standards: The Thomson Reuters Trust Principles., opens new tab

 * Suggested Topics:
 * Healthcare & Pharmaceuticals
 * Healthcare & Pharmaceuticals

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Purchase Licensing Rights


READ NEXT

 * Boards, Policy & RegulationcategoryBig pharma pushes Trump team to ease
   Medicare drug price negotiation rules
 * Healthcare & PharmaceuticalscategoryFDA probes blood cancer risk from
   bluebird's gene therapy, weighs regulatory action
 * LegalcategoryTransgender care at issue in US Supreme Court's latest culture
   war fight
 * Healthcare & PharmaceuticalscategoryHealth Rounds: Widely used thyroid pill
   may be linked to bone loss
 * Healthcare & PharmaceuticalscategoryGrifols shares tumble after Brookfield
   drops takeover plan




BUSINESS




 * WHAT THE ADANI ALLEGATIONS HIGHLIGHT ABOUT INDIA'S CLEAN ENERGY PUSH
   
   ANALYSIS · November 28, 2024 · 2:20 AM GMT+1 · 16 min ago
   
   Bribery allegations against Adani Group founder Gautam Adani have highlighted
   the growing problem India's renewable energy developers face in finding
   buyers for the power they generate.

 * TechnologycategoryIntel's $7.86 billion subsidy deal restricts sale of its
   manufacturing unit2:02 AM GMT+1 · Updated 34 min ago
 * categoryEuro jump, rising yen put brakes on the dollar1:56 AM GMT+1 · Updated
   40 min ago
 * ANALYSISAustralia's hot jobs market keeps rate cuts out of reach1:55 AM GMT+1
   · Updated 41 min ago
 * MarketscategoryMexico warns Trump tariffs would kill 400,000 US jobs,
   threatens retaliation1:48 AM GMT+1 · Updated an hour ago




SITE INDEX


LATEST

 * Home
 * Authors
 * Topic Sitemap
 * Archive
 * Article Sitemap


BROWSE

 * World
 * Business
 * Markets
 * Sustainability
 * Legal
 * Breakingviews
 * Technology
 * Investigations
 * Sports
 * Science
 * Lifestyle


MEDIA

 * 
   Videos
 * 
   Pictures
 * 
   Graphics
 * 
   Podcasts


ABOUT REUTERS

 * About Reuters, opens new tab
 * Careers, opens new tab
 * Reuters News Agency, opens new tab
 * Brand Attribution Guidelines, opens new tab
 * Reuters and AI, opens new tab
 * Reuters Leadership, opens new tab
 * Reuters Fact Check
 * Reuters Diversity Report, opens new tab


STAY INFORMED

 * Download the App (iOS), opens new tab
 * Download the App (Android), opens new tab
 * Newsletters


INFORMATION YOU CAN TRUST

Reuters, the news and media division of Thomson Reuters, is the world’s largest
multimedia news provider, reaching billions of people worldwide every day.
Reuters provides business, financial, national and international news to
professionals via desktop terminals, the world's media organizations, industry
events and directly to consumers.


FOLLOW US

 * X
 * Facebook
 * Instagram
 * Youtube
 * Linkedin


THOMSON REUTERS PRODUCTS

 * WESTLAW, OPENS NEW TAB
   
   BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT,
   ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY.

 * ONESOURCE, OPENS NEW TAB
   
   THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING
   TAX AND COMPLIANCE NEEDS.

 * CHECKPOINT, OPENS NEW TAB
   
   THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE
   PROFESSIONALS.


LSEG PRODUCTS

 * WORKSPACE, OPENS NEW TAB
   
   ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED
   WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE.

 * DATA CATALOGUE, OPENS NEW TAB
   
   BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND
   INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS.

 * WORLD-CHECK, OPENS NEW TAB
   
   SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER
   HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS.

 * Advertise With Us, opens new tab
 * Advertising Guidelines
 * Purchase Licensing Rights, opens new tab

 * Cookies, opens new tab
 * Terms of Use
 * Privacy, opens new tab
 * Digital Accessibility, opens new tab
 * Corrections
 * Site Feedback, opens new tab

All quotes delayed a minimum of 15 minutes. See here for a complete list of
exchanges and delays.

© 2024 Reuters. All rights reserved






WE VALUE YOUR PRIVACY

We and our 152 partners will store and access information on your device with
your consent. Browsing data is collected through the use of cookies to process
personal data. You can give or withdraw your consent by clicking on the `Show
Purposes` button. You can manage your choices and exercise your right to object
on the basis of legitimate interest at any time by clicking on the cog icon at
the bottom left corner of every page.Cookie PolicyPrivacy Statement


HOW AND WHY WE PROCESS PERSONAL DATA

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

Allow All Reject All Show Purposes


Feedback